Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Peripheral Nervous System Diseases × Surveys and Questionnaires × Clear all

Phase

Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

cyclopia sequence 1 Tobacco Use Cessation 1 Prostatic Neoplasms 1 Peripheral Nervous System Diseases 1 Nocturia 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Hodgkin Disease 1 Health Education 1 Carcinoma, Non-Small-Cell Lung 1 Bronchiolitis Obliterans Syndrome 1 Breast Neoplasms 1 Advanced Cancers 1

Interventions

Trimetazidine 1 Thioctic Acid 1 Surveys and Questionnaires 1 Paclitaxel 1 Cilostazol 1 Carnosine 1 Acupuncture Therapy 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02168894 2016-03-08

SINF: Peripheral Neuropathy in Cancer Survivors

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn

Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡